Close
Nordic 9Nordic 9

XGEN Venture (investor - Venture Capital)

Italy xgenventure.com
See something wrong or missing? Let us know
Offices:Milano

XGEN Venture is an Italian investment company backing next generation life science ventures.

  • in 2024, XGEN Ventures announced raising €180 million for its debut fund
Average round investment:41.46M USD
Average number per year:2.0
Distribution: 2024 (3)2023 (1)
Portfolio companies: Italy GenespireItaly Tes PharmaGermany Protembis See the entire list
Mostly invests in: Italy Italy (2) Health services (4)
See the entire list

Showing 3 of 4 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to XGEN Venture

Name Criteria
Denmark Sunstone Life Science Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy, Germany, Switzerland
  • Average number of deals per year: 2.0
  • Active last 12 months: Yes
Germany Bosch Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Wearable, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Italy, Germany, Switzerland
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Belgium Korys
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Ireland Seroba Life Sciences
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Hardware, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy, Germany
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States In-Q-Tel
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Italy, Germany, Switzerland
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United States +ND Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 1.8
  • Active last 12 months: Yes
Spain BBVA
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Hardware
  • Similar business models: B2B
  • Common investees countries: Germany
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
Belgium V-Bio Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Italy
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
Switzerland Novartis Venture Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Germany, Switzerland
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United States Pfizer Venture Investments
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Pharma
  • Similar business models: B2B
  • Common investees countries: Switzerland
  • Average number of deals per year: 2.5
  • Active last 12 months: Yes
Top